STAAR Surgical Stock Surges 21% After Q2 Sales Beat Expectations; Uplifts FY21 Outlook
STAAR Surgical Company (NASDAQ:STAA) Q2 sales increased 77% Y/Y to $62.4 million and up 23% on a sequential basis, beating the…
Staar Surgical Q2 EPS $0.27 Up From $0.03 YoY, Sales $62.40M Beat $52.56M Estimate
Staar Surgical (NASDAQ:STAA) reported quarterly earnings of $0.27 per share. This is a 800 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $62.40
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Oppenheimer Initiates Coverage On Staar Surgical with Perform Rating, Announces Price Target of $150
Oppenheimer analyst Steven Lichtman initiates coverage on Staar Surgical (NASDAQ:STAA) with a Perform rating and announces Price Target of $150.
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs.
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 39 companies set new 52-week highs.
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 188 stocks made new 52-week highs.